Matthew J. WestbrookAssociateProskauer Rose LLPWebsitewww.proskauer.com/Organization ProfileFull ProfileConnectEmail202-416-6864 Professional Biography Matthew Westbrook is an associate in the Corporate Department and a member of the Health Care Group. More Legal and Business Bylines From Matthew J. Westbrook DOJ Begins Issuing Demand Letters to Contractors Under New Civil Rights Fraud Initiative - (Posted On Tuesday, September 02, 2025) No Surprises Here! Payers Push Back on IDR Submissions, Opening New Front in NSA Implementation Landscape - (Posted On Wednesday, July 23, 2025) DOJ Targets Gender‑Affirming Care under FDCA and FCA: Scrutinizes Off‑Label Drug Use and False Diagnosis Codes - (Posted On Thursday, July 17, 2025) No Surprises Here! Fifth Circuit Holds NSA Provides No Private Right of Action to Enforce IDR Awards, Deepening Judicial Divide on Award Enforcement Mechanisms - (Posted On Monday, June 30, 2025) DOJ’s Civil Rights Fraud Initiative: Key Considerations for Health Care Providers - (Posted On Thursday, May 29, 2025) CMS to Immediately Begin Auditing Medicare Advantage Plans in Significant Expansion of Enforcement Efforts - (Posted On Tuesday, May 27, 2025) Disproportionate Impact: Supreme Court Narrows Disproportionate Share Hospital Reimbursement to Supplemental Security Income Cash Recipients - (Posted On Friday, May 23, 2025) Post‑Chevron Spotlight: Federal Court Nixes FDA Rule Reclassifying Laboratory Services as Medical Devices - (Posted On Tuesday, April 15, 2025) HHS Scraps Richardson Waiver, Clearing Way for Faster Rulemaking - (Posted On Thursday, March 13, 2025) First Circuit Clarifies FCA Liability Standard for AKS Violations, Deepening Circuit Split - (Posted On Tuesday, February 25, 2025) Pagination Page 1 Next page Next › Current Legal Analysis Implications for ECI Risk in Debt Investments - IRS Private Letter Ruling 202536015 by: Pallav Raghuvanshi WashU Law’s Bold Bid to Become the Global Leader in Legal AI by: Eliya France Nasdaq Proposes to Allow Trading of Tokenized Securities by: Wai L Choy , Louis Rambo Five Takeaways from the FTC’s Decision to Abandon the Noncompete Rule by: Taylor Appling , Benjamin R. Dryden AI Chatbots in the Medical Field: Healthcare Hero or HIPAA Nightmare? by: Amy Hill Mintz IRA Update — Still Undefeated: Government Notches Three More Victories in Negotiation Program Lawsuits by: Theresa C. Carnegie , Mitchell J. Clough The Washington Supreme Court’s Decision in Branson v. Washington Fine Wine & Spirits LLC and Its Significance for Employers by: Robert T. Dumbacher , Meredith Gregston Mintz IRA Update — PhRMA’s 2025 Policy Agenda and the Industry’s Crossroads with the IRA and Drug Pricing Reform by: Theresa C. Carnegie , Ayaz R. Shaikh Mintz IRA Update — 340B Roundup: HRSA Launches 340B Rebate Model Pilot Program Amid Ongoing Legal and Regulatory Shifts by: Lauren M. Moldawer , Xavier G. Hardy Mintz IRA Update — 340B Roundup: States and Manufacturers Continue to Battle over 340B Contract Pharmacies by: Lauren M. Moldawer , Xavier G. Hardy DExit Why Some Companies Are Leaving Delaware [Video] by: Louis Lehot , Beth I. Z. Boland Healthcare Preview for the Week of: September 15, 2025 by: Debra Curtis , Rodney Whitlock, Ph.D 340B Roundup: Senate HELP Committee’s Long-Awaited 340B Report Highlights Ongoing Problems but Provides Few Solutions by: Lauren M. Moldawer , Xavier G. Hardy Court Blocks Texas AG’s Enforcement of New Proxy Advisor Law by: John Thomas Holland , Thomas Woolsey California Federal Court Allows Massachusetts Chapter 93A Claim to Proceed to Discovery by: David G. Thomas , Angela C. Bunnell Upcoming Events Sep 18 2025 Workplace Horizons Extension: Chicago Sep 29-30 2025 Intellectual Property Law Institute 2025 - New York Oct 20-21 2025 Intellectual Property Law Institute 2025 - California Oct 21-22 2025 2025 Proxy Disclosure & 22nd Annual Executive Compensation Conferences Print
